Revenue
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2020
2021
2022
2023
2024
2025
Gyre Therapeutics, Inc. (GYRE)
Price$6.86Cached quote
Net income
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $116.6M | $105.8M | $113.5M | $102.3M | $7.3M | $20.9M | — | $6,000 | $1.0M | $399,000 | $1.8M | $275,000 | $3.6M | $57.9M | $97.6M | $85.7M | $25.1M |
| Gross profit | $111.2M | $101.9M | $108.8M | $97.5M | — | — | — | — | — | — | — | — | — | — | — | — | $24.4M |
| Gross margin | 95.35% | 96.33% | 95.91% | 95.31% | — | — | — | — | — | — | — | — | — | — | — | — | 97.24% |
| Research & development | $13.7M | $12.0M | $13.8M | $16.7M | $68.9M | $53.0M | $43.9M | $21.5M | $12.8M | $11.6M | $6.0M | $5.3M | $6.6M | $49.1M | $95.2M | $64.5M | $40.2M |
| Operating expenses | $105.1M | $89.6M | $180.7M | $93.1M | $95.2M | $78.3M | $57.3M | $33.8M | $22.8M | $20.8M | $15.6M | $9.3M | $10.6M | $66.0M | $107.4M | $72.6M | $65.4M |
| Operating income | $11.5M | $16.2M | −$67.2M | $9.2M | −$87.9M | −$57.4M | −$57.3M | −$33.8M | −$21.8M | −$20.4M | −$13.8M | −$7.5M | −$10.1M | −$8.1M | −$9.7M | $13.1M | −$40.3M |
| Operating margin | 9.85% | 15.28% | −59.26% | 9.00% | −1,197.79% | −273.87% | — | −563,700.00% | −2,143.61% | −5,117.29% | −788.69% | −2,730.55% | −278.86% | −14.06% | −9.98% | 15.30% | −160.90% |
| EBITDA | $14.0M | $17.7M | −$66.2M | $10.3M | −$87.6M | −$57.2M | −$57.1M | −$33.7M | −$21.6M | −$20.0M | −$13.3M | −$6.8M | −$9.1M | −$5.9M | −$7.3M | $15.1M | −$38.5M |
| EBITDA margin | 11.98% | 16.75% | −58.31% | 10.06% | −1,193.84% | −273.21% | — | −561,216.67% | −2,126.62% | −5,019.80% | −761.83% | −2,483.27% | −252.03% | −10.24% | −7.44% | 17.63% | −153.58% |
| Net income | $9.9M | $17.9M | −$85.5M | $4.3M | −$87.9M | −$56.2M | −$55.2M | −$30.1M | −$21.6M | −$16.9M | −$14.8M | −$6.6M | −$10.0M | −$7.0M | −$8.5M | $10.9M | −$39.4M |
| Net profit margin | 8.47% | 16.92% | −75.35% | 4.22% | −1,198.32% | −268.48% | — | −500,916.67% | −2,117.98% | −4,246.87% | −843.54% | −2,404.73% | −274.62% | −12.09% | −8.74% | 12.72% | −157.23% |
| Basic EPSper basic share | $0.06 | $0.14 | -$1.41 | $0.04 | -$2.87 | -$2.93 | -$4.60 | -$2.68 | -$7.45 | -$21.75 | -$49.99 | -$269.85 | -$409.35 | -$286.65 | -$368.55 | $518.70 | -$2,102.10 |
| Diluted EPSper diluted share | $0.02 | $0.05 | -$1.41 | $0.03 | -$2.87 | -$2.93 | -$4.60 | -$2.68 | -$7.45 | -$21.75 | -$49.99 | -$269.85 | -$409.35 | -$286.65 | -$368.55 | $491.40 | -$2,102.10 |
Owners
Reported shareholders
3.54%of listed shares
HSG Holding Ltd3.75M shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
HSG Holding Ltd | 3.54%3.75M shares |
Ma Songjiang | ≈2.65%2.81M shares |
Luo Ying | ≈2.42%2.57M shares |
BlackRock, Inc. | 0.94%993.94K shares |
Octagon Capital Advisors LP | 0.90%954.42K shares |
VANGUARD CAPITAL MANAGEMENT LLC | 0.83%876.93K shares |
GEODE CAPITAL MANAGEMENT, LLC | 0.50%532.95K shares |
STATE STREET CORP | 0.23%245.4K shares |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.17%184.29K shares |
NORTHERN TRUST CORP | 0.16%169.54K shares |
SBI Securities Co., Ltd. | 0.16%166.75K shares |
VANGUARD FIDUCIARY TRUST CO | 0.14%151.07K shares |
VANGUARD PORTFOLIO MANAGEMENT LLC | 0.12%123.95K shares |
GOLDMAN SACHS GROUP INC | 0.08%86.24K shares |
Bank of New York Mellon Corp | 0.06%62.75K shares |
MORGAN STANLEY | 0.04%41.69K shares |
STRS OHIO | 0.02%25.8K shares |
DIMENSIONAL FUND ADVISORS LP | 0.02%25.27K shares |
ALLIANCEBERNSTEIN L.P. | 0.02%24.59K shares |
Nuveen, LLC | 0.02%24.51K shares |
Percentages use 106.03M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 18, 2026Form 4 | Ye WeiguoChief Operating Officer | SellCommon Stock | 3.0K | $6.35 | $19.1K | 700.0K |
| Jun 11, 2026Form 4 | Ye WeiguoChief Operating Officer | SellCommon Stock | 2.8K | $6.17 | $17.3K | 700.0K |
| Jun 10, 2026Form 4 | Ye WeiguoChief Operating Officer | SellCommon Stock | 5.0K | $6.24 | $31.2K | 700.0K |
| Jun 10, 2026Form 4 | Ye WeiguoChief Operating Officer | SellCommon Stock | 6.4K | $6.21 | $39.9K | 700.0K |
| Jun 9, 2026Form 4 | Ye WeiguoChief Operating Officer | SellCommon Stock | 3.0K | $6.15 | $18.4K | 700.0K |